{
  "timestamp": "20250104_024905",
  "model": "gpt-4o",
  "interaction_type": "answer_with_enhancement_without_enhancer",
  "question_id": "427393cb",
  "question_text": "Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n                    You are a medical expert determining the final answer.\n\n            ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n\n\n                    ### Question\n                    Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008\n\n                    ### Options\n                    opa. Succinylcholine\nopb. Tubocurare\nopc. Pyridostigmine\nopd. Halothane\n\n### Enhanced Information (For Contextual Support):\nIn patients with myasthenia gravis, the use of succinylcholine is contraindicated. Succinylcholine is a depolarizing neuromuscular blocker that can exacerbate muscle weakness, which aligns with the consensus that it should be avoided in myasthenia gravis. The evidence path supports this by linking depolarizing neuromuscular blockers to muscle weakness (paresis), which is a concern in myasthenia gravis. Tubocurare, a non-depolarizing neuromuscular blocker, can also increase muscle weakness, but it is not as strongly contraindicated as succinylcholine. Pyridostigmine, an acetylcholinesterase inhibitor, is used to improve neuromuscular transmission in myasthenia gravis and is not contraindicated. Halothane, a general anesthetic, does not directly affect the neuromuscular junction in a way that would contraindicate its use in myasthenia gravis. Therefore, succinylcholine is the most contraindicated option for a patient with myasthenia gravis.\n\n                    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n\n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n                    "
    }
  ],
  "response": "{\n  \"final_analysis\": \"In patients with myasthenia gravis, the use of neuromuscular blockers is a critical consideration due to their potential to exacerbate muscle weakness. Succinylcholine, a depolarizing neuromuscular blocker, is particularly contraindicated because it can cause prolonged muscle paralysis in these patients. This is due to the fact that myasthenia gravis patients have a reduced number of functional acetylcholine receptors, and succinylcholine's mechanism of action can lead to excessive depolarization and subsequent muscle weakness. Tubocurare, while also a neuromuscular blocker, is non-depolarizing and not as strongly contraindicated as succinylcholine. Pyridostigmine is actually used to treat myasthenia gravis by improving neuromuscular transmission. Halothane, a general anesthetic, does not have a direct contraindication in myasthenia gravis related to neuromuscular transmission. Therefore, based on standard medical knowledge and consensus, succinylcholine is the most contraindicated drug in this context.\",\n  \"answer\": \"opa\",\n  \"confidence\": 95\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}